• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AGN

ARGENICA THERAPEUTICS LIMITED - Corporate Spotlight

4.29% ! 33.5¢
Market Cap $43.03M  !

Argenica Therapeutics Limited is an Australia-based biotechnology company, developing... Argenica Therapeutics Limited is an Australia-based biotechnology company, developing novel therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The Company's lead neuroprotective peptide candidate, ARG-007, has been demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischemic encephalopathy (HIE). The Company has completed a Phase I clinical trial in healthy human volunteers to assess the safety and tolerability of a single dose of ARG-007. It has completed dosing in a Phase II clinical trial in ischaemic stroke patients and continues to generate preclinical data in other neurological conditions, including in TBI and HIE.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
33.5¢
Change
-0.015(4.29%)
Mkt cap ! $43.03M
Open High Low Value Volume
35.5¢ 36.0¢ 32.5¢ $567.3K 1.672M

Buyers (Bids)

No. Vol. Price($)
2 62344 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 23645 1
View Market Depth
Last trade - 16.10pm 11/09/2025 (20 minute delay) ?
Last
33.0¢
  Change
-0.015 ( 6.28 %)
Open High Low Volume
34.0¢ 35.5¢ 32.5¢ 262132
Last updated 15.58pm 11/09/2025 ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.